Zambia like other MeTA pilot countries is developing strategies to promote
greater transparency and accountability regarding policies, practices, and outcomes in
the pharmaceutical sector. A survey looking at four areas; Medicines registration
and quality assurance; Availability of medicines; Price of medicines, Policies and practices concerning the promotion of medicines, was conducted. Data was collected using a disclosure tool.
For each core area, disclosed information should cover policies – the laws and regulations that are in place; practices – suggested procedures to follow and
actual practices; and results – achievements in the core area. The objectives of
describing the current disclosure status of information in the core areas are to:
- enable the Zambia MeTA Council to prioritize potential activities to facilitate progressive disclosure over time; and
- create a baseline against which changes in transparency and disclosure during pilot implementation can be measured.